Cancer
At the Kolling Institute, our cancer research aims to identify and overcome the factors that drive cancer development so that we can improve patient outcomes. We have a number of cancer research teams with different expertise, specialising in chemotherapy resistance, immunotherapies, genetics, epigenetics, diagnostic services and clinical trials. Importantly, these teams have access to an active tissue bank and the latest equipment.
Our cancer research rapidly implements laboratory findings into clinical practice and is supported by the Cancer Institute Translational Centre, Sydney Vital. By bringing together research scientists, clinicians and allied health professionals, we are able to combine innovative and cutting edge research with personalised treatment strategies for cancer patients.
Find out more about:
Bill Walsh Translational Cancer Research Laboratory
Bowel Cancer and Biomarker Research Lab
Breast Cancer Research
Cancer Genetics Laboratory
Events, News and Seminars
International focus on our ovarian cancer research
Posted on: 02 March, 2020
In an exciting breakthrough, researchers from the Kolling Institute’s Bill Walsh Lab have identified..... Read more
Category: Research Excellence
Home grown ideas place physio in patients' hands
Posted on: 24 February, 2020
New research is testing a new way to meet the rapidly growing demand for physiotherapy in our publi..... Read more
Category: New Treatment
Common medication may lower risk of “heartbreak”
Posted on: 14 February, 2020
RNSH cardiologist Professor Geoffrey Tofler has led a world-first study which found that common med..... Read more
Category: Research Excellence